COVID19 research - illumina brand novaseq reagent kits (ambis #2173402)

Ended Awarded Last action

Contract number
75N93023F00011
Awardee
Awarding agency
Obligated
$107,866

Award facts

Contract value 100% obligated
$107,866.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92122, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · The purpose of this modification is to close the delivery/task order in the amount of $107,866.08. $0
Original award $107,866

About this award

The National Institute of Allergy and Infectious Diseases issued a $107,866.08 firm-fixed-price delivery order to Illumina, Inc. on May 8, 2023, for Illumina NovaSeq reagent kits supporting COVID-19 research (AMBIS #2173402). The order was issued without a set-aside. Place of performance is San Diego, CA 92122. The period of performance ended May 7, 2024. A modification closes the order at $107,866.08, the same amount as its ceiling value.

Quick answers

Who was awarded contract 75N93023F00011?

75N93023F00011 was awarded to Illumina, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 8, 2023.

How much is contract 75N93023F00011 worth?

The government has obligated $107,866 on 75N93023F00011.

Is contract 75N93023F00011 an order under another contract?

Yes. 75N93023F00011 is a delivery order under 75N92020D00022, an indefinite delivery contract.

Was contract 75N93023F00011 competed?

The extent of competition for 75N93023F00011 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award